Christopher Franklin Devall sold $173k of DOMH
COO at AIkido Pharma Inc.. 45,000 shares at an average of $3.85, traded Dec 8, 2025, filed Dec 10, 2025.
Score components
- +20RoleCOO
- +11Trade size$173k at market
- +5Share of holdings soldSold 24% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +12.4%, 3m -14.2%, 6m -10.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-119865, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | SOpen-market sale Common Stock | -45,000 | $3.85 | $173k | 145,702 | Dec 10, 2025 |
Related signals
Other insiders at AIkido Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | AIkido Pharma Inc. | Kyle Michael Wool President | $209k 100,000 shares | +2% | |
| 45Moderate | AIkido Pharma Inc. | Anthony Hayes CEO | $209k 100,000 shares | +2% | |
| 50Moderate | AIkido Pharma Inc. | Anthony Hayes CEO | $89k 23,000 shares | +1% | |
| 46Moderate | AIkido Pharma Inc. | Kyle Michael Wool President | $97k 25,000 shares | +1% | |
| 46Moderate | AIkido Pharma Inc. | Kyle Michael Wool President | $97k 25,000 shares | +2% | |
| 50Moderate | AIkido Pharma Inc. | Anthony Hayes CEO | $89k 23,000 shares | +1% | |
| 63Notable | DOMHsell AIkido Pharma Inc. | Christopher Franklin Devall COO | $871k 220,000 shares | -54% | |
| 42Moderate | AIkido Pharma Inc. | Kyle Michael Wool President | $11k 5,000 shares | +22% | |
| 41Moderate | AIkido Pharma Inc. | Anthony Hayes CEO | $11k 4,640 shares | +2% | |
| 43Moderate | AIkido Pharma Inc. | Kyle Michael Wool President | $25k 8,500 shares | +46% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.